other
confidence high
sentiment neutral
materiality 0.15
Biostage adopts annual say-on-pay votes after stockholder advisory vote
Harvard Apparatus Regenerative Technology, Inc.
- Advisory vote: 7,539,731 shares favored one year, 28,038 three years, 110,760 abstained.
- Board decided to hold future say-on-pay votes annually until next frequency vote (no later than 2028).
- Amendment solely discloses frequency decision; no other changes to original 8-K from June 22, 2022.